HSK47388

DRUG3 trials

Sponsors

Haisco Pharmaceutical Group Co., Ltd.

Conditions

HealthyPlaque PsoriasisUlcerative Colitis (UC)

Phase 1

This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers

Not yet recruitingNCT06926218

Haisco Pharmaceutical Group Co., Ltd.Healthy

Start: 2025-05-31End: 2025-09-30Target: 40Updated: 2025-04-13

Phase 2

A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

Not yet recruitingNCT07158268

Haisco Pharmaceutical Group Co., Ltd.Plaque Psoriasis

Start: 2025-09-01End: 2027-01-17Target: 220Updated: 2025-09-05

A Study for HSK47388 in Participants With Ulcerative Colitis

RecruitingNCT07335055

Haisco Pharmaceutical Group Co., Ltd.Ulcerative Colitis (UC)

Start: 2026-02-03End: 2029-02-02Target: 150Updated: 2026-03-05